Technology-Assisted Interventions for Substance Use Disorders

Mashal Khan

ISBN 10: 3031264479 / ISBN 13: 9783031264474

Published by Springer Nature Switzerland, 2024

About this Item

Druck auf Anfrage Neuware - Printed after ordering - This book examines the role of technology-assisted interventions for substance use disorders (SUD). It considers this topic alongside the dramatic increase in SUDs and associated harm in the United States' past decade.Chapters relay the impact and effectiveness of technology-assisted interventions, which include telemedicine, assisted therapies, and support. These treatments not only offer practical care but also address the issue of access to care, particularly in the wake of the global pandemic (COVID-19). Organized into three sections, section one covers the use of telemedicine and technology-assisted therapies as it relates to the treatment of various SUDs, achieving recovery and maintenance. Each chapter will expand on a specific aspect of technology-assisted intervention. Following this, section two explores the differences in technology-assisted interventions and approaches while taking into account age, gender, sexuality, identity, and psychosocial factors. This section will be divided into chapters on children and adolescents, women and pregnancy, older adults, LGBTQIA+, and professionals. To close the book, section three discusses the media impact on SUDs and the legal technology adopted by drug courts.Unique and timely, Technology-Assisted Interventions for Substance Use Disorders is an invaluable resource to learners and practitioners in the field. It provides a concise yet comprehensive summary of the current status of the field that will help guide the implementation of technology-assisted interventions for all SUDs into practice and stimulate investigative efforts.

Seller Inventory # 9783031264474

Bibliographic Details

• Title: Technology-Assisted Interventions for Substance Use Disorders
• Publisher: Springer Nature Switzerland
• Publication Date: 2024
• Language: English
• ISBN 10: 3031264479
• ISBN 13: 9783031264474
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 254W x 178H x 8D millimeters 254 millimeters width by 178 millimeters height by 8 millimeters depth
• Weight: 310 grams

About this title

Synopsis

This book examines the role of technology-assisted interventions for substance use disorders (SUD). It considers this topic alongside the dramatic increase in SUDs and associated harm in the United States’ past decade.

Chapters relay the impact and effectiveness of technology-assisted interventions, which include telemedicine, assisted therapies, and support. These treatments not only offer practical care but also address the issue of access to care, particularly in the wake of the global pandemic (COVID-19). Organized into three sections, section one covers the use of telemedicine and technology-assisted therapies as it relates to the treatment of various SUDs, achieving recovery and maintenance. Each chapter will expand on a specific aspect of technology-assisted intervention. Following this, section two explores the differences in technology-assisted interventions and approaches while taking into account age, gender, sexuality, identity, and psychosocial factors. This section will be divided into chapters on children and adolescents, women and pregnancy, older adults, LGBTQIA+, and professionals. To close the book, section three discusses the media impact on SUDs and the legal technology adopted by drug courts.

Unique and timely, Technology-Assisted Interventions for Substance Use Disorders is an invaluable resource to learners and practitioners in the field. It provides a concise yet comprehensive summary of the current status of the field that will help guide the implementation of technology-assisted interventions for all SUDs into practice and stimulate investigative efforts.

 

About the Author

Jonathan Avery, M.D.

Vice Chair, Addiction Psychiatry

Stephen P. Tobin and Dr. Arnold M. Cooper Associate Professor in Consultation-Liaison Psychiatry

Program Director, Addiction Psychiatry Fellowship

Program Director, Opioid Overdose Prevention Program

Weill Cornell Medicine I New York-Presbyterian

New York, NY 

Mashal Khan, M.D 

Assistant Professor of Clinical Psychiatry

Asst. Program Director, Addiction Psychiatry Fellowship

Assistant Professor of Clinical Psychiatry

Weill Cornell Medicine I New York-Presbyterian

New York, NY.